Personalis Inc
PSNL·Stocks·Medical Or Nursing Services·United States·Nasdaq·USD
Price
$16.29
Today
+0.7%
YTD
+105.0%
About
Personalis, Inc. is a cancer genomics company. Offering advanced genomic sequencing and analytics, it provides information for cancer therapy development, selection, and diagnostics. Operating internationally, Personalis has its headquarters in Menlo Park, California, and was founded in 2011. The company is listed on the NASDAQ GM under the ticker PSNL. For the most recent PSNL stock news, add this instrument to your eToro watchlist.
Price chart
Closing price history for PSNL (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-14.92
P/S (TTM)24.64
P/B (TTM)7.36
Market cap$1.74B
Cap tierSmall-cap
Industry avg P/E-597.87
Profitability
Gross margin12.69%
EBIT margin-164.07%
Net margin-141.71%
ROE-50.32%
ROA-37.55%
Earnings & Revenue
Revenue (TTM)$69.67M
Revenue growth (1Y)-13.3%
EPS (TTM)-$1.09
Free cash flow$-100.97M
Total debt$38.00M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)2.18
Employees260
Next earnings3 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.